News archive

The Conference "Women of NeurotechEU: Empower, Lead, Innovate" is an international event organized by the “Iuliu Hațieganu” University of Medicine and Pharmacy in Cluj-Napoca, under the umbrella of the NeurotechEU European University Alliance, in connection with International Women’s Day.

“Journées CORTICO 2026”, the symposium in the fields of Brain-Computer Interfaces (BCI), Neurotechnology and Cognitive Neuroscience, will take place on May 18-20, 2026, at the University of Lille, France.

Adolescents who report pain at the age of 18 are at higher risk of later self-harm. This is shown by a new study from Karolinska Institutet, published in Psychiatry Research. The findings suggest that pain may form part of the chain of events leading to self-harming behaviour.

Prolonged exposure to air pollution can be linked to an elevated risk for serious neurodegenerative diseases like ALS and seems to speed up the pathological process, report researchers from Karolinska Institutet in Sweden. The study is published in the journal JAMA Neurology.

A new study shows that internet-delivered cognitive behavioural therapy (ICBT) can effectively reduce asthma-related anxiety in adults with asthma. Participants who received ICBT reported less anxiety related to their asthma, better asthma control, higher quality of life, and fewer avoidance behaviours compared to those who received standard care. Lung function was not affected by the treatment, indicating that it is safe and can be used as a complement to medical asthma treatment.

Bachelor, Master, and PhD students at Karolinska Institutet (KI) are invited to apply now for the Autumn School of Clinical Neurotechnology taking place 23-26 February in Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca (Romania).

The NeurotechEU Internship Program at Boğaziçi University offers undergraduate and master’s students from the NeurotechEU alliance a unique opportunity to gain hands-on research experience in cutting-edge neuroscience and neurotechnology laboratories.

Researchers at Karolinska Institutet have discovered that the nervous system's own immune cells help protect the spinal cord from age-related damage. The results, which may contribute to new knowledge about how certain neurological diseases arise, are published in the journal Nature Neuroscience.

The Epilepsy Foundation (Stiftelsen Epilepsifonden) is awarding a grant of SEK 400,000 to the research project “MAP-KETO,” which is investigating the effects of a ketogenic diet on children with drug-resistant epilepsy.

Forced to flee as a child, today Elham Rostami saves lives in emergency situations – and conducts research to understand why some patients with brain injuries recover unexpectedly well. 

A new study from Karolinska Institutet, published in Nature Communications, reveals an unexpected role for immature glial cells known as oligodendrocyte progenitor cells (OPCs) in shaping the developing human brain.

A new study shows that visual and tactile impressions that are related to our own body are prioritised for reaching conscious awareness. This helps us understand how we develop the feeling that the body is our own – through the brain’s integration of what we see and what we feel.

The popular NeurotechEU Internship Program at the University of Bonn is returning in the Summer of 2026 — and KI bachelor's and master's students can now apply!

Researchers, clinicians, students, and patient representatives gathered at Karolinska Institutet for the 2025 KI Pain Network Conference, a full-day event dedicated to the latest advances in pain research and care.

KI Master’s, PhD, and early-career researchers are invited to apply for the Winter School on Brain Architecture for NeuroAI and Neurotechnology: A Systems Neuroscience Perspective, taking place at the Universidad Miguel Hernández de Elche.

The BonnBrain Conference 2026 will take place in Bonn, Germany, from March 23–25, 2026, bringing together leading neuroscientists from across Europe and beyond to discuss the latest advances in brain research.

A treatment that could protect premature babies from brain damage showed promise in a recent study in Sweden. Using a first-of-its-kind prenatal brain model created with human cells researchers observed new details about the effects of cerebral hemorrhages on stem cells during premature birth. And they successfully tested an antidote that reduced the damage.

In a significant step for European collaboration in neuroscience and technological innovation, the Medical University of Innsbruck (MUI) has officially joined The European University of Brain and Technology – NeurotechEU.

Researchers from Karolinska Institutet and Albert Einstein College of Medicine have shown that glioblastoma, the most aggressive form of brain cancer, not only affects the brain but also erodes the skull and alters the immune system in the bone marrow. The findings are published in Nature Neuroscience.

On Friday, September 26, StratNeuro and StratRegen proudly took part in ForskarFredag in Stockholm, held at AlbaNova and Vetenskapens Hus

Bachelor, Master, and PhD students at KI are invited to apply now for the Autumn School of Clinical Neurotechnology taking place in Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca (UMF Cluj)

Glaucoma is the most common cause of irreversible blindness worldwide. Pete Williams wants to find new ways of treating this disease by protecting and restoring nerve cells in the eye. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 9 October.

When the Swedish Foundation for Strategic Research (SSF) selected the research leaders of the future three years ago as part of the prestigious programme ‘Future Research Leaders’ (FFL), KI researcher Arvid Guterstam was one of the 16 selected. The award offers researchers the opportunity to further develop their research with a grant of SEK 15 million over a five-year period. Halfway through the programme, Arvid Guterstam talks here about his results within the framework of the programme.

Flavoured drinks without sugar can be perceived as sweet – and now researchers know why. A new study from Karolinska Institutet, published in the journal Nature Communications, reveals that the brain interprets certain aromas as taste.

Among young people, the use of sleep medication has increased sharply – despite ongoing questions about the drugs’ effectiveness and long-term impact. Researchers now recommend psychological treatment instead.

This intensive blended learning course equips PhD researchers with the entrepreneurial mindset, skills, and tools needed to transform scientific discoveries into viable innovations.

KI researcher and PhD supervisor Robert Harris is ranked number 5 on the list ‘Top 20 LinkedIn Influencers in Sweden in 2025’ by the AI-based ranking platform Favikon.

This funding initiative is designed to support researchers in the development of innovative technologies and methods to advance our understanding of the nervous system in both health and disease. The grant specifically prioritized high-risk, high-reward projects with the potential for wide impact across the neuroscience community.

The scientific review of the Center for Innovative Medicine (CIMED) project applications is now complete. Award decisions have been made by the CIMED Board of Directors following the recommendation of the review panels.

Glaucoma is the most common cause of irreversible blindness and affects 80 million people around the world. Pete Williams, researcher at Karolinska Institutet and St Erik Eye Hospital, has now been awarded a prestigious ERC Advanced Grant for his work on new treatments for the disease. The ERC Advanced Grant is one of the most eminent awards a researcher can receive.

As part of the KI NeurotechEU Collaborative Award 2025, PhD student Jianing Lin from Karolinska Institutet undertook a valuable educational visit to Prof. Ruiz de Almodóvar’s lab at Rheinische Friedrich-Wilhelms-Universität Bonn in Germany. Supported by the NeurotechEU alliance, this short-term exchange provided hands-on training, networking opportunities, and the foundation for a new cross-institutional collaboration in the field of neurovascular biology.

Each project has been awarded 3 million SEK over a two-year period.

From the 13th of October to the 16th, Final-year Master’s students in the field of neurotechnology, PhD candidates, post-doctoral and early-career researchers are invited to attend 3 days of training at the Université de Lille and one optional day dedicated to a cultural visit.

Mats J Olsson, professor at the Department of Clinical Neuroscience (CNS), has accepted an extension of his appointment as Head of the Department.

On May 27–28, over 270 researchers, clinicians, and students gathered at the scenic Djurönäset conference center for the StratNeuro Retreat 2025

Fredrik Piehl, Professor of Neurology at the Department of Clinical Neuroscience at Karolinska Institutet and researcher at Karolinska University Hospital, has been named Neuroprofile of the Year 2025.

The Bridging Grant is a funding initiative through which StratNeuro provides support to promising researchers with outstanding scientific merits, offering them the opportunity to further consolidate and strengthen their research.

A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. Promising results have been published in the journal Cell Reports Medicine. The researchers behind the study have now started a clinical trial on patients.

The Docent Committee decided on the 29 of April 2025 to admit Kyla McKay as docent in public health, global health and social medicine.

On March 1st, Kristina Aspvall took over as the new Director of Research school for clinicians in psychiatry.

On Saturday, March 15th, StratNeuro hosted the annual En Resa Genom Härnan event as part of Brain Awareness Week 2025.

The Committee for Research at Karolinska Institutet has, after a careful inventory, decided to award Eric Thelin's research group, active at the Department of Clinical Neuroscience, SEK 730,000 from a donation bequeathed by Erik Gut.

New research suggests that antidepressants can accelerate cognitive decline in people with dementia. At the same time, some drugs appear to be less harmful than others, which can help doctors make better treatment decisions, according to the study published in BMC Medicine.

We are pleased to invite you to the interdisciplinary NeurotechEU Summer School "Trust me! Neural Networks, Manipulation, and Ethics" at the University of Bonn, taking place 8-11 September 2025.

Researchers at Karolinska Institutet in Sweden have discovered a fundamental mechanism that affects the size of the pupil, namely our breathing. The study, published in The Journal of Physiology, shows that the pupil is smallest during inhalation and largest during exhalation – something that could affect our vision.

StratNeuro aims to support the development and dissemination of new technologies and therefore announces a new round of this funding call.

KI NeurotechEU steering group is pleased to announce the availability of limited competitive funds for KI faculty, staff and/or students to conduct collaborative interactions within the field of Neurotechnology.

We congratulate Tobias Granberg, Docent and research group leader at the Department of Clinical Neuroscience (CNS), appointed adjunct professor of neuroradiology.

The Academy of Behavioral Medicine Research (ABMR) awards Josefin Särnholm the Neal Miller New Investigator Award.

The ability to plan several steps ahead and promptly adapt to a rapidly changing environment is essential to being an elite footballer, a new study led from Karolinska Institutet reports. The paper, which is published in the scientific journal PNAS, also shows that it helps not to always be so agreeable.